BACKGROUND: Quetiapine improves both psychotic symptoms and cognitive function in schizophrenia. The neural basis of these actions is poorly understood. METHODS: Three subject groups underwent a single functional magnetic resonance imaging (fMRI) session: drug-naive (n = 7) and quetiapine-treated samples of patients with schizophrenia (n = 8) and a healthy control group (n = 8). The fMRI session included an overt verbal fluency task and a passive auditory stimulation task. RESULTS: In the verbal fluency task, there was significantly increased activation in the left inferior frontal cortex in the quetiapine-treated patients and the healthy control sample compared with the drug-naive sample. During auditory stimulation, the healthy control group and stably treated group produced significantly greater activation in the superior temporal gyrus than the drug-naive sample. CONCLUSIONS: Quetiapine treatment is associated with altered blood oxygen level-dependent responses in both the prefrontal and temporal cortex that cannot be accounted for by improved task performance subsequent to drug treatment.
BACKGROUND:Quetiapine improves both psychotic symptoms and cognitive function in schizophrenia. The neural basis of these actions is poorly understood. METHODS: Three subject groups underwent a single functional magnetic resonance imaging (fMRI) session: drug-naive (n = 7) and quetiapine-treated samples of patients with schizophrenia (n = 8) and a healthy control group (n = 8). The fMRI session included an overt verbal fluency task and a passive auditory stimulation task. RESULTS: In the verbal fluency task, there was significantly increased activation in the left inferior frontal cortex in the quetiapine-treated patients and the healthy control sample compared with the drug-naive sample. During auditory stimulation, the healthy control group and stably treated group produced significantly greater activation in the superior temporal gyrus than the drug-naive sample. CONCLUSIONS:Quetiapine treatment is associated with altered blood oxygen level-dependent responses in both the prefrontal and temporal cortex that cannot be accounted for by improved task performance subsequent to drug treatment.
Authors: Nicolas A Crossley; Andrea Mechelli; Paolo Fusar-Poli; Matthew R Broome; Pall Matthiasson; Louise C Johns; Elvira Bramon; Lucia Valmaggia; Steven C R Williams; Philip K McGuire Journal: Hum Brain Mapp Date: 2009-12 Impact factor: 5.038
Authors: P Fusar-Poli; M R Broome; P Matthiasson; J B Woolley; A Mechelli; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire Journal: Schizophr Bull Date: 2009-08-07 Impact factor: 9.306
Authors: Tyler A Lesh; Costin Tanase; Benjamin R Geib; Tara A Niendam; Jong H Yoon; Michael J Minzenberg; J Daniel Ragland; Marjorie Solomon; Cameron S Carter Journal: JAMA Psychiatry Date: 2015-03 Impact factor: 21.596
Authors: E M Meisenzahl; J Scheuerecker; M Zipse; S Ufer; M Wiesmann; T Frodl; N Koutsouleris; T Zetzsche; G Schmitt; M Riedel; I Spellmann; S Dehning; J Linn; H Brückmann; H J Möller Journal: Eur Arch Psychiatry Clin Neurosci Date: 2006-12-06 Impact factor: 5.270
Authors: Sergi G Costafreda; Cynthia H Y Fu; Marco Picchioni; Fergus Kane; Colm McDonald; Diana P Prata; Sridevi Kalidindi; Muriel Walshe; Vivienne Curtis; Elvira Bramon; Eugenia Kravariti; Nicolette Marshall; Timothea Toulopoulou; Gareth J Barker; Anthony S David; Michael J Brammer; Robin M Murray; Philip K McGuire Journal: Hum Brain Mapp Date: 2009-10 Impact factor: 5.038
Authors: Xin Gao; Wenjing Zhang; Li Yao; Yuan Xiao; Lu Liu; Jieke Liu; Siyi Li; Bo Tao; Chandan Shah; Qiyong Gong; John A Sweeney; Su Lui Journal: J Psychiatry Neurosci Date: 2018-03 Impact factor: 6.186